Metabolic Derangements in Acute Heart Failure Syndrome

NeuroTherapia, Inc.

Status: Terminated

Conditions: Congestive Heart Failure

Treatments: Other: Observational

Study type: Observational

Funder types: Other

Identifiers

NCT00682175

08-169

Details and patient eligibility

About

To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult (age > 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.

Exclusion criteria

• History of Congenital Heart Disease.
• Acute HF in the setting of acute myocardial infarction.
• Severe Anemia
• Patients listed for cardiac transplantation.
• Terminal Malignancy, AIDS or CNS disease.
• Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

Trial design

100 participants in 1 patient group

Observation

Description:

Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit with Acute Heart Failure Syndrome requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.

Treatment:

Other: Observational